<DOC>
	<DOCNO>NCT01758640</DOCNO>
	<brief_summary>A prospective , randomize , longitudinal , open label , parallel group clinical trial design compare proportion failure reach INR target 2.5-3.5 either : small dose warfarin ( &lt; 5 mg/day ) phenindione ( &lt; 100 mg/day ) , high-risk pregnant non-pregnant patient bileaflet mechanical heart valve prosthesis .</brief_summary>
	<brief_title>Safety And Efficacy Low Dose Oral Anticoagulants And Aspirin Therapy</brief_title>
	<detailed_description>The patient choose main population 3000 females child bearing period ( 18-40 year ) , bileaflet mechanical mitral ( + aortic ) valve prosthesis , regular follow-up outpatient clinic Ain Shams University Hospitals . Patients primarily screen wiliness participate study express clear wish become pregnant ( Subpopulation A : 310 patient ) otherwise make clear decision become pregnant follow regular contraceptive measure ( Subpopulation B : 660 patient ) . Study group A ( pregnant ) B ( non-pregnant ) create assess respective subpopulation follow eligibility criterion ( ) regular menstrual cycle history congenital malformation , repeat abortion still birth ; ( b ) patient NYHA class I II c ) regular INR record last 3 month , target INR achieve warfarin exceed 10 mg/day ; ) patient accept participate study ; ( ) get pregnant Group A patient , course Patients exclude either group refuse participate study sign inform consent . Pregnant patient exclude Group A reporting missed menstrual period positive pregnancy test later 6th week gestation . Patients exclude Group B whenever get pregnant , course . A total 100 patient intend recruit group . Out 104 patient meet inclusion criterion Group A , 4 case exclude report pregnancy late 9th 12th week ( 2 case ; 1.9 % ) refuse sign inform consent ( 2 case ; 1.9 % ) . Out 135 patient meet inclusion criterion Group B , much 35 patient ( 25.9 % ) exclude refuse participate study . Randomization treatment allocation : In order become formal Group A member , patient subpopulation A followed conception , clear instruction report 3 day miss menstrual period confirm pregnancy repeatedly perform pregnancy test every 3 day menstruate . Legible patient group sign inform consent randomize . We use simple 8 element randomization table , 6 element assign warfarin 2 element assign phenindione , create 2 separate randomization list . Each list use randomize recruited 100 patient group either : low dose warfarin ( &lt; 5 mg/day ) phenindione ( &lt; 100 mg/day ) , 3:1 ratio ; respectively . In patient assigned latter , phenindione replace warfarin start dose 50 mg/day ( 25 mg /day patient weigh &lt; 40 kg . ) , INR repeat 4 day dose adjust accordingly . All patient target INR 2.5 3.5 . Follow-up : Patients follow till delivery ( Group A ) whole 9 month 's period ( Group B ) . During time , patient benefit monthly cardiac examination , bimonthly check hepatorenal function complete blood picture well echocardiographic examination . In addition , Group A patient benefit monthly obstetrical examination sonography . All patient instruct report complication immediately , Group A , prescribed drug revise attend obstetrician . Prothrombin time ( PT ) do DADE BEHRING CA 1500 INR check day randomization , 4 day , 2 week regularly monthly basis . Starting second trimester ( Group A ) fourth month follow-up ( Group B ) , 100 mg aspirin add case . Patients present INR &lt; 20 % target subject clinical examination special emphasis dietary / bowel habit , recently receive medication INR repeat 4 day manage suspected cause . Patients still fail reach low target well initially present INR 2 shift oral anticoagulant . The start dose latter calculated basis anticoagulation effect 1 mg warfarin roughly equivalent achieve 10 mg phenindione ( unpublished experience ) . In shift , INR gap bridge LMWH 1 mg/kg , give twice daily . Patients fail reach low INR target maximum allow daily dose oral anticoagulant exclude study . Fortnight delivery , Group A patient hospitalized oral anticoagulant substitute continuous infusion UFH plan delivery 36th week per vagina Caesarian section , indicate .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Phenindione</mesh_term>
	<criteria>Regular menstrual cycle history congenital malformation , repeat abortion still birth . Patients NYHA class I II c ) regular INR record last 3 month , target INR achieve warfarin exceed 10 mg/day . Patient accept participate study Getting pregnant Group A patient Patients exclude either group refuse participate study sign inform consent . Pregnant patient exclude Group A reporting missed menstrual period positive pregnancy test later 6th week gestation . Patients exclude Group B whenever get pregnant .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>mechanical heart valve</keyword>
	<keyword>pregnancy</keyword>
	<keyword>warfarin</keyword>
	<keyword>phenindione</keyword>
</DOC>